Pharmaids Pharmaceuticals Limited (PHARMAID.BO)
INR 58.5
(0.03%)
INR 58.5
(0.03%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 151.12 Million | - | 39.39 Million | 85.51 Million | - | 5.61 Million |
| Cost of Revenue | 223.93 Million | 8.87 Million | 35.71 Million | 81.59 Million | 388.02 Thousand | 3.56 Million |
| Gross Profit | -72.81 Million | -8.87 Million | 3.67 Million | 3.91 Million | -388.02 Thousand | 2.04 Million |
| Operating Expenses | 76.49 Million | 90.15 Million | 2.39 Million | 3.18 Million | 3.69 Million | 3.12 Million |
| Selling, General and Administrative Expenses | 76.49 Million | 94.43 Million | 609.56 Thousand | 418.69 Thousand | 1.08 Million | 428.07 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -4.42 Million | 151 Thousand | 263.4 Thousand | -453.5 Thousand | 1000.00 |
| Cost and Expenses | 300.43 Million | 99.03 Million | 38.11 Million | 84.77 Million | 3.69 Million | 6.69 Million |
| Operating Income | -149.31 Million | -99.03 Million | 1.27 Million | 732 Thousand | -3.69 Million | -1.47 Million |
| Interest Expense | 15.68 Million | 46 Thousand | 27 Thousand | 42.00 | 8401.00 | 169.00 |
| Income Tax Expense | -37.78 Million | -23.52 Million | -49 Thousand | -48.76 Thousand | -4.08 Million | 343.16 Thousand |
| Earnings before Tax | -156.21 Million | -99.07 Million | 1.4 Million | 884.34 Thousand | -3.75 Million | -1.43 Million |
| Net Income | -79.68 Million | -75.55 Million | 1.45 Million | 933.11 Thousand | 335.33 Thousand | -1.77 Million |
| Earnings Per Share Basic | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 |
| Earnings Per Share Diluted | -3.71 | -5.86 | 0.14 | 0.09 | 0.03 | -0.17 |
| Weighted Average Shares Outstanding | 21.48 Million | 12.89 Million | 10.31 Million | 10.31 Million | 10.31 Million | 10.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.48 Million | 12.89 Million | 10.31 Million | 10.31 Million | 10.31 Million | 10.31 Million |
| Gross Margin | -0.48 | - | 0.09 | 0.05 | - | 0.37 |
| EBIT Margin | -0.82 | - | 0.04 | 0.02 | - | -0.10 |
| Profit Margin | -0.53 | - | 0.04 | 0.01 | - | -0.32 |
| EBITDA | -123.28 Million | -98.87 Million | 1.37 Million | 1.33 Million | -3.35 Million | -965.13 Thousand |
| Earnings Before Tax Margin | -0.99 | - | 0.03 | 0.01 | - | -0.26 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 46.74 Million | 151.12 Million | 58.05 Million | 208 Thousand | - | - |
| Cost of Revenue | 73.37 Million | 223.93 Million | 84.4 Million | 187 Thousand | 87 Thousand | 82 Thousand |
| Gross Profit | -26.62 Million | -72.81 Million | -26.35 Million | 21 Thousand | -87 Thousand | -82 Thousand |
| Operating Expenses | 13.1 Million | 76.49 Million | 35.76 Million | 13.11 Million | 10.29 Million | 16.15 Million |
| Selling, General and Administrative Expenses | 13.1 Million | - | 35.76 Million | 4.4 Million | 10.2 Million | 16.07 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 94 Thousand | 8.78 Million | 16.64 Million | -9.01 Million | -2.57 Million | 3.72 Million |
| Cost and Expenses | 86.47 Million | 300.43 Million | 120.17 Million | 13.29 Million | 10.29 Million | 16.15 Million |
| Operating Income | -39.73 Million | -149.31 Million | -62.11 Million | -13.09 Million | -10.29 Million | -16.15 Million |
| Interest Expense | 2.61 Million | 15.68 Million | 7.66 Million | - | 1000.00 | 12 Thousand |
| Income Tax Expense | -11.76 Million | -37.78 Million | -5.32 Million | -5.75 Million | -7.82 Million | 935 Thousand |
| Earnings before Tax | -43.01 Million | -156.21 Million | -68.58 Million | -22.1 Million | -12.87 Million | -12.06 Million |
| Net Income | -26.84 Million | -79.68 Million | -55.19 Million | -16.34 Million | -5.04 Million | -13 Million |
| Earnings Per Share Basic | -0.76 | - | -2.57 | -0.76 | -0.23 | -0.61 |
| Earnings Per Share Diluted | -0.76 | - | -2.57 | -0.76 | -0.23 | -0.61 |
| Weighted Average Shares Outstanding | 35.26 Million | 21.48 Million | 21.48 Million | 21.48 Million | 21.48 Million | 21.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.26 Million | 21.48 Million | 21.48 Million | 21.48 Million | 21.48 Million | 21.48 Million |
| Gross Margin | -0.57 | -0.48 | -0.45 | 0.10 | - | - |
| EBIT Margin | -0.73 | - | -0.96 | -62.25 | - | - |
| Profit Margin | -0.57 | -0.53 | -0.95 | -78.58 | - | - |
| EBITDA | -34.07 Million | - | -55.79 Million | -12.94 Million | -12.78 Million | -11.97 Million |
| Earnings Before Tax Margin | -0.85 | -0.99 | -1.07 | -62.93 | - | - |
FUAPF
DXYZ
0396
PSYTF
300056
BAFN